Greater Impact of Melanocortin-4 Receptor Deficiency on Rates of Growth and Risk of Type 2 Diabetes During Childhood Compared With Adulthood in Pima Indians
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Features of melanocortin-4 receptor (MC4R) deficiency have been observed to be more pronounced in childhood. Longitudinal data from a population-based study were used to separate the phenotypic effects of MC4R deficiency during childhood and adulthood. The MC4R exon was sequenced in 6,760 individuals of predominantly Pima Indian heritage, and discovered mutations were functionally assessed in vitro. Effects on BMI, height, and slope of BMI change were assessed during childhood (ages 5–20 years) and adulthood (ages 20–45 years). Six mutations affecting MC4R function, including three that may be private to Pima Indians, were found in 159 individuals (2.4%). The slope of BMI increase was greater in individuals carrying an MC4R mutation compared with noncarriers during childhood but not during adulthood. The final adult height obtained was higher in individuals with MC4R deficiency. There was an increased risk for developing type 2 diabetes in individuals with a defective MC4R during childhood and adulthood, but this was only independent of BMI in childhood. The greater rates of body mass accumulation and risk of type 2 diabetes before the age of 20 years in individuals with MC4R deficiency indicate that the effects of these mutations are more apparent during the active growth of childhood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene
Farooqi, I. S., Keogh, J. M., Yeo, G. S. H., Lank, E. J., Cheetham, T., & O'Rahilly, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022050 · Cited by 1,778
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., & Froguel, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9238 · Cited by 897 · cited 2×
“Others have not found an increased prevalence of type 2 diabetes among adults with MC4R deficiency (5,9,25), but we did find a modest risk of developing type 2 diabetes during adulthood that was fully attributable to the increased BMI.”
BackgroundResultThirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies
The GIANT Consortium, Elks, C. E., Perry, J. R. B., Sulem, P., Chasman, D. I., Franceschini, N., He, C., Lunetta, K. L., Visser, J. A., Byrne, E. M., et al. (2010) · Nature Genetics · doi:10.1038/ng.714 · Cited by 504
Modulation of Blood Pressure by Central Melanocortinergic Pathways
Greenfield, J. R., Miller, J. W., Keogh, J. M., Henning, E., Satterwhite, J. H., Cameron, G. S., Astruc, B., Mayer, J. P., Brage, S., See, T. C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0803085 · Cited by 477 · cited 4×
“Others have not found an increased prevalence of type 2 diabetes among adults with MC4R deficiency (5,9,25), but we did find a modest risk of developing type 2 diabetes during adulthood that was fully attributable to the increased BMI.”
BackgroundResultInfluentialSchulz, L. O., Bennett, P. H., Ravussin, E., Kidd, J. R., Kidd, K. K., Esparza, J., & Valencia, M. E. (2006) · Diabetes Care · doi:10.2337/dc06-0138 · Cited by 420
Lifestyle Intervention in Obese Children With Variations in the Melanocortin 4 Receptor Gene
Reinehr, T., Hebebrand, J., Friedel, S., Toschke, A. M., Brumm, H., Biebermann, H., & Hinney, A. (2009) · Obesity · doi:10.1038/oby.2008.422 · Cited by 166 · cited 1×
“MC4R deficiency has been reported to lead to an early increase in stature (7,8,28), although not every study has confirmed this finding (2,30).”
BackgroundMartinelli, C. E., Keogh, J. M., Greenfield, J. R., Henning, E., van der Klaauw, A. A., Blackwood, A., O'Rahilly, S., Roelfsema, F., Camacho-Hübner, C., Pijl, H., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1369 · Cited by 153 · cited 3×
“The effect on linear growth may be related to the severity of MC4R deficiency, which would explain why our study, with partial loss-of-function mutations, found a relatively small effect and another recent study demonstrated a larger effect on final adult height of 5–7 cm in individuals heterozygous for complete loss-…”
BackgroundResultGenetic Studies of the Etiology of Type 2 Diabetes in Pima Indians
Baier, L. J., & Hanson, R. L. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1181 · Cited by 109
Self-citationSympathetic Function in Human Carriers of Melanocortin-4 Receptor Gene Mutations
Sayk, F., Heutling, D., Dodt, C., Iwen, K. A., Wellhoner, J. P., Scherag, S., Hinney, A., Hebebrand, J., & Lehnert, H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2297 · Cited by 86
Cited by
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Lakshman, R., Elks, C. E., & Ong, K. K. (2012) · Circulation · doi:10.1161/circulationaha.111.047738 · Cited by 318
Iepsen, E. W., Zhang, J., Thomsen, H. S., Hansen, E. L., Hollensted, M., Madsbad, S., Hansen, T., Holst, J. J., Holm, J.-C., & Torekov, S. S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.008 · Cited by 156
Loss-of-function mutations in the melanocortin 4 receptor in a UK birth cohort
Wade, K. H., Lam, B. Y. H., Melvin, A., Pan, W., Corbin, L. J., Hughes, D. A., Rainbow, K., Chen, J.-H., Duckett, K., Liu, X., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01349-y · Cited by 133
Trier, C., Hollensted, M., Schnurr, T. M., Lund, M. A. V., Nielsen, T. R. H., Rui, G., Andersson, E. A., Svendstrup, M., Bille, D. S., Gjesing, A. P., et al. (2021) · International Journal of Obesity · doi:10.1038/s41366-020-00673-6 · Cited by 38
“viously found not to reduce MC4R activity in vitro [13, 28, 29, 32, 36, 37], were classified as benign.”
Background
Metadata
- Authors
- Thearle, M. S., Muller, Y. L., Hanson, R. L., Mullins, M., AbdusSamad, M., Tran, J., Knowler, W. C., Bogardus, C., Krakoff, J., & Baier, L. J.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-12-12
- Volume
- 61
- Issue
- 1
- Pages
- 250-257
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2129234601
- Cited by
- 62
- References
- 9
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.